Article
Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer.
Molecular carcinogenesis - 1 Sept 2009
Misra Chaitali, Majumder Mousumi, Bajaj Swati, Ghosh Saurabh, Roy Bidyut, Roychoudhury Susanta
Abstract excerpt
Polymorphisms at loci controlling cellular processes such as cell cycle, DNA repair, and apoptosis may modulate the risk of cancer. We examined the association of two linked polymorphisms (G4C14-A4T14) at p73 and one polymorphism (309G > T) at MDM2 promoter with the risk of leukoplakia and oral cancer. The p73 and MDM2 genotypes were determined in 197 leukoplakia patients, 310 oral cancer patients and in 348...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
